Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors

Abstract The potential for adoptive cell immunotherapy as a treatment against cancers has been demonstrated by the remarkable response in some patients with hematological malignancies using autologous T cells endowed with chimeric antigen receptors (CARs) specific for CD19. Clinical efficacy of CAR-...

Full description

Bibliographic Details
Main Authors: Erhao Zhang, Jieyi Gu, Hanmei Xu
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Molecular Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12943-018-0759-3